Keyphrases
Inflammasome Activation
100%
Primary Monocytes
100%
Kinase Activity
100%
NOD-like Receptor Protein 3 (NLRP3)
100%
Receptor-interacting Protein Kinase 1 (RIPK1)
100%
Interleukin-1β
100%
Convalescent COVID-19
100%
Retinoic Acid-inducible Gene I (RIG-I)
100%
Gasdermin D (GSDMD)
45%
Alternative Pathway
45%
Toll-like Receptor 4 (TLR4)
36%
Pyroptosis
36%
Innate Immune Receptors
28%
Trained Immunity
28%
Monocytes
27%
K+ Efflux
27%
Toll-like
27%
Secondary Signal
18%
Mild Symptoms
14%
Antiviral Response
14%
Innate Immune Signaling Pathways
14%
Initial Infection
14%
DDX58
14%
Epigenetic Reprogramming
14%
Receptor 1
14%
Human Support
9%
Interferon-α (IFN-α)
9%
Toll-like Receptor 8 (TLR8)
9%
TIR Domain
9%
Death Domain
9%
Inflammasome
9%
Pore Formation
9%
Toll-like Receptor 7 (TLR7)
9%
Toll-like Receptor 2 (TLR2)
9%
TLR1
9%
Dual-ligand
9%
Unconventional Secretory Pathway
9%
Adapter
9%
Inflammasome Pathway
9%
Adaptor Protein
9%
Caspase-1
9%
Caspase-8
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nucleotide Binding Oligomerization Domain Like Receptor
100%
Protein Kinases
100%
Pyrin
100%
Receptor
100%
Toll Like Receptor 4
100%
Phosphotransferase
100%
Inflammasome
100%
Retinoic Acid
100%
Pyroptosis
80%
Effusion
60%
Potassium Ion
60%
Toll Like Receptor
40%
Toll Like Receptor 1
20%
Toll Like Receptor 2
20%
Interferon
20%
Caspase 8
20%
Toll Like Receptor 8
20%
Adaptor Protein
20%
Interleukin 1beta Converting Enzyme
20%
Toll Like Receptor 7
20%
Immunology and Microbiology
Interleukin-1
100%
NOD-like Receptor
100%
Inflammasome
100%
Pyrin Domain
100%
TLR4
45%
Gasdermin D
45%
Pyroptosis
36%
Immune System Receptors
28%
TRIF
27%
Toll-Like Receptor
18%
Monocyte Response
14%
Channel Gating
9%
Caspase
9%
Maturation
9%
Secretory Pathway
9%
Cell Line
9%
Death Domain
9%
interferon
9%
TLR2
9%
TLR 1
9%
Caspase 1
9%
Monocyte Like Cell
9%
TLR8
9%
TLR7
9%